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Introduction
Flubendazole (FLU) is a benzimidazole anthelmintic with a wide spectrum of activity against endoparasites. After administration, FLU has a low bioavailability as more than 50 % of the administered dose is excreted unchanged in the faeces (www.emea.europa.eu/htms/vet/mrls/). An advantage of low levels of gastrointestinal absorption may be the higher amount of anthelmintic agent in the intestinal lumen that remains in contact with the gastrointestinal parasites (roundworms, tapeworms). Helminths, though, can be located in other internal organs, and in such cases the only effective treatment is through absorption and systemic distribution of the active anthelmintic compound into the ..... host's body. FLU, however, is rapidly biotransformed in the gastrointestinal tract and liver: plasmatic concentrations of FLU metabolites prevail over the concentration of the parent drug (www.emea.europa.eu/htms/vet/mrls/). The main biotransforming pathway of FLU involves reduction of the ketone functional group and hydrolysis of the carbamate moiety. Ketoreduction, resulting in reduced FLU (FLU-R), is the major metabolic pathway in chickens, turkeys, and sheep, whereas carbamate hydrolysis, resulting in hydrolyzed FLU (FLU-H), is the major metabolic pathway in pigs (Moreno et al. 2004, www.emea.europa . eu/htms/vet/mrls/). Although information on the anthelmintic activity of FLU metabolites may be valuable for the estimation of the complex efficacy of FLU administration to farm animals, no relevant data are available. Moreover, some parasites are also able to biotransform FLU: e.g., FLU-R formation was found in the adult stage of Haemonchus contortus (Rudolphi, 1803) (Cvilink et al., 2008) . The impact of ketoreduction on FLU's anthelmintic properties -impairment or deactivation -has not been studied to date. Addressing these facts, the present in vitro study was designed to compare the anthelmintic effects of FLU and its metabolites on two isolates of H. contortus, one fully susceptible to benzimidazoles and one multiply resistant to anthelmintics, using a modified in vitro larval development test (Várady et al., 2007) that is able to distinguish between susceptible and resistant isolates of H. contortus. Thiabendazole (TBZ) was used as a reference anthelmintic in this test.
Materials and methods

Chemicals
Flubendazole ([5-(4-fluoro-benzoyl)-1H-benzimidazole-2-y1]carbamic acid methyl ester, FLU) and its two main metabolites racemic reduced flubendazole ((±)- [5-(4-HELMINTHOLOGIA, 47, 4: 269 -272, 2010 Research Note 
Trial design
Prior to the trial, both isolates were routinely maintained by passage through worm-free Merino lambs 5-6 months of age that were housed individually. Lambs were infected orally with 5000 -6000 L 3 larvae of each isolate. Faecal samples were collected on day 30 and day 35 after inoculation, and nematode eggs for larval development tests were collected by differential sieving through three stacked sieves of 250-, 100-, and 25-µm mesh, successively. The material retained on the 25-µm mesh sieve was washed with water, sedimented, and floated with saturated sodium chloride (Coles et al., 1992) , followed by washing over a 20-µm mesh sieve with water. The eggs obtained were subsequently used for in vitro tests.
In vitro larval development test
The procedure used was a modification by Várady et al. (1996) of the technique described earlier (Hubert & Kerboeuf, 1992) . The modified method that was used in the current study differs from the method described by Hubert and Kerboeuf (1992) . In tests, 96-well microtitre plates were incubated at 27°C. On day 7, the incubation was terminated by addition of 10 μl of Lugol's solution into each well, and the numbers of unhatched eggs and L 1 -L 3 larvae in each well were counted under an inverted microscope. The test was performed in two replicates for each drug concentration and was repeated in two independent experiments.
Data analysis
Results of the larval development tests are presented as LC 50 and LC 99 values, which are defined as the anthelmintic concentrations where the development of eggs to the L 3 stage is inhibited by 50 % and 99 %, respectively. The data were analyzed using a logistic regression model to determine LC 50 and LC 99 (Dobson et al., 1987) . The LC 50 gives information on the resistance of the average worm in the population, and LC 99 shows which proportion of the population is the most resistant. Significant differences (P ≤ 0.05) 
Results and discussion
The in vitro larval development test in this study was chosen due to its sensitivity, reproducibility, and ease of interpretation (Várady et al., 2007) . (Table 2) show a negligible efficacy of FLU-H, which was approximately 360 -852 times lower than the efficacy of FLU. In the case of FLU-R, an efficacy 6-and 13-times lower than the efficacy of FLU was found in HCR and HCS, respectively. Based on these results, FLU-H appears to be an inactive product of FLU biotransformation. The reduction of FLU can also be considered a deactivation reaction, but the deactivation is not complete as partial anthelmintic activity of FLU-R is retained. The residual anthelmintic efficacy of FLU-R may contribute to the total anthelmintic effect of FLU administration, especially in birds and sheep where the plasmatic concentration of FLU-R is more than 10-fold higher than the FLU concentration (Moreno et al., 2004; Křížová et al., 2009) . Another anthelmintic drug, mebendazole, is a chemical relative of FLU. Mebendazole and FLU differ only in one fluorine atom and they undergo the same biotransformation pathways -carbonyl reduction and carbamate hydrolysis (www.emea.europa.eu/htms/vet/mrls/). In contrast to FLU, no anthelmintic activity was found for either metabolite of mebendazole (Meuldermans et al., 1976) .This fact demonstrates a strong dependence of anthelmintic activity on the chemical structure of drugs. The anthelmintic efficacies of TBZ, FLU, FLU-R, and FLU-H in HCS and HCR were compared using resistance factor (RF) values (Table 3 ). The distinction between HCS and HCR isolates is more evident in RF 99 than in RF 50 . As shown earlier (Várady et. al., 2007) contortus. However, it is important to bear in mind that third-stage larvae, which were used in our study, are not the main target of anthelmintic treatments. Therefore, verification of our results by in vivo testing is necessary.
